Cox-maze IV cryoablation and postoperative heart failure in mitral valve surgery patients^*

Abstract

Objective: The indications for and the risk and benefit of concomitant surgical ablation for atrial fibrillation (AF) have not been fully delineated. Our aim was to survey whether the Cox-maze IV procedure is associated with postoperative heart failure (PHF) or other adverse short-term outcomes after mitral valve surgery (MVS).

Design: Consecutive patients with AF undergoing MVS with (n = 50) or without (n = 66) concomitant Cox-maze IV cryoablation were analysed regarding perioperative data and one-year mortality.

Results: The patients in the Maze group were younger, were in lower NYHA classes, had better right ventricular function and had lower pulmonary artery pressure. The Maze group had 30 min longer median cross-clamp time (CCT) and 50% had PHF compared with 33% in the No-maze group, p = 0.09. Two patients in the No-maze group died within one year of surgery. Congestive heart failure (OR 4.3 [CI 95%: 1.8–10], p < 0.0001) and CCT (OR 1.03 [CI 95%: 1.01–1.04], p = 0.001) were associated with PHF.

Conclusion: The current data cannot exclude that concomitant cryoablation increases the risk for PHF, possibly by increasing the cross clamp time.

Keywords:

• Atrial fibrillation
• mitral valve
• outcome
• postoperative heart failure

Acknowledgements

The authors thank Karl Wahlin and Mats Fredrikson for their contribution to the statistical analyses.

Disclosure statement

The authors report no relationship with industry and no conflicts of interest.

Funding information

Financial support was received from the ALF funding, County Council of Östergötland, Sweden.